In previous studies, we demonstrated that PGRMC1 is partially required for progestin signaling in MCF7 cells and therefore suggested a potential role of PGRMC1 in the increased breast cancer risk upon progestin-based HT [27,28,29]. The gene discussed is PGRMC1; the disease is breast carcinoma.